Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8003549 | 0.97 | HDAC8 (0.32) | HDAC8 | |
| SCHEMBL11985917 | 0.52 | KDM4E (0.31) | — | |
| SCHEMBL21290178 | 0.39 | KDM4E (0.32) | — | |
| Calcium Chloride SCHEMBL5381230 | 0.35 | — | — | |
| SCHEMBL22400163 | 0.33 | — | — | |
| SCHEMBL21870554 | 0.33 | — | — | |
| SCHEMBL2587040 | 0.33 | — | — | |
| Calcium Chloride SCHEMBL23441478 | 0.32 | — | — | |
| Calcium Chloride SCHEMBL21751993 | 0.32 | — | — | |
| Calcium Chloride SCHEMBL23803973 | 0.32 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1201657-B1 | Imidazolium salts and the use of these ionic liquids as a solvent and as a catalyst | CENTRE NAT RECH SCIENT (FR) | 2004-05-06 | — | — | EP | claimed |
| US-6525228-B2 | Reacting a conjugated diene with a compound containing active hydrogen in the presence of a cataylst system comprising a transition metal compound, a phosphorus containing compound and atleast one salt | CELANESE CHEMICALS EUROPE GMBH (DE) | 2003-02-25 | — | — | US | disclosed |
| US-20020091281-A1 | Process of telomerizing conjugated dienes | CELANESE CHEMICALS EUROPE GMBH (DE) | 2002-07-11 | — | — | US | disclosed |
| EP-1201634-A1 | Process of telomerizing conjugated dienes | Celanese Chemicals Europe GmbH (DE) | 2002-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091281-A1 | Process of telomerizing conjugated dienes | TELO2, TERT, PCNA | HDAC8 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.